San Diego, CA, United States of America

Celine Bonnefous


 

 

Average Co-Inventor Count = 5.3

ph-index = 6

Forward Citations = 125(Granted Patents)


Company Filing History:


Years Active: 2006-2018

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Celine Bonnefous: Innovator in Androgen and Estrogen Receptor Modulation

Introduction

Celine Bonnefous is a prominent inventor based in San Diego, CA, known for her significant contributions to the field of pharmaceutical sciences. With a total of 12 patents to her name, she has made remarkable strides in developing compounds that target androgen and estrogen receptors.

Latest Patents

Her latest patents include "Androgen receptor modulators and uses thereof," which describes compounds that act as androgen receptor modulators. This patent outlines pharmaceutical compositions and medicaments that incorporate these compounds, along with methods for using them to treat diseases or conditions mediated by androgen receptors. Another notable patent is "Polycyclic estrogen receptor modulators and uses thereof," which details compounds that function as estrogen receptor modulators. Similar to her work on androgen receptors, this patent also discusses pharmaceutical compositions and methods for treating conditions dependent on estrogen receptors.

Career Highlights

Celine has worked with notable companies in the pharmaceutical industry, including Aragon Pharmaceuticals, Inc. and Seragon Pharmaceuticals, Inc. Her work has been instrumental in advancing therapeutic options for various medical conditions.

Collaborations

Celine has collaborated with esteemed colleagues such as Nicholas D. Smith and Jackaline Dalgard Julien, contributing to a dynamic research environment that fosters innovation.

Conclusion

Celine Bonnefous stands out as a leading inventor in the realm of receptor modulation, with her patents paving the way for new treatments in medicine. Her dedication to research and development continues to impact the pharmaceutical landscape significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…